reported complete property of $269.1 million for the yr ended December 31, 2025, in comparison with $7.3 million on the finish of 2024, based on an organization assertion. The medical gadget gross sales and distribution firm collected over 2 million tokens as a part of its digital asset treasury technique.
The corporate generated roughly $7.0 million in complete income for fiscal yr 2025, with $6.8 million coming from internet staking income and $204,120 from medical gadget distribution. Sharps reported that roughly 95% of its SOL holdings are actively staked at a 7% gross annualized yield.
Stockholders’ fairness elevated to $264.4 million from $2.0 million at year-end 2024, whereas complete liabilities decreased to $4.7 million. The corporate eradicated a $3.8 million notes payable steadiness that existed on the finish of 2024 and reported optimistic working capital of $14.2 million.
Sharps raised over $430 million in complete capital throughout 2025 by way of fairness choices and warrant workouts, together with money, digital asset, and stablecoin contributions. The corporate launched its validator by way of Coinbase’s institutional infrastructure and established partnerships with Crypto.com, BitGo, Jupiter Alternate, The Tie, Bonk, and Pudgy Penguins.
“Throughout the yr, we reworked the Firm’s steadiness sheet, accomplished our strategic shift away from unprofitable legacy working actions, established a treasury place of greater than 2 million SOL,” mentioned Paul Ok. Danner, Government Chairman.
The corporate phased out legacy manufacturing actions whereas constructing its SOL treasury place. Sharps filed its Annual Report on Type 10-Ok for 2025 with the Securities and Alternate Fee on March 31, 2026.
